中国核电 reported revenue of ¥38.40B for the period ended 2026-06-30, -6.3% year on year. Net income was ¥7.11B, a 18.5% net margin on a 36.5% gross margin. The largest revenue line is 核电 at 80% of the total. Free cash flow for the period was ¥-3.10B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥38.40B | -6.3% |
| Gross profit | ¥14.00B | — |
| Operating income | ¥9.21B | — |
| Net income | ¥7.11B | -36.0% |
| Gross margin | 36.5% | Net margin 18.5% |
| Revenue Q/Q | +2.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 核电 | ¥30.79B | 80.2% |
| 光伏 | ¥3.89B | 10.1% |
| 风电 | ¥2.60B | 6.8% |
| 其他 | ¥0.49B | 1.3% |
| 核电相关服务 | ¥0.42B | 1.1% |
| 储能 | ¥0.21B | 0.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥24.39B | 63.5% |
| R&D | ¥0.36B | 0.9% |
| SG&A | ¥1.57B | 4.1% |
| Tax & other | ¥2.11B | 5.5% |
| Item | Amount |
|---|---|
| Total assets | ¥787.67B |
| Total liabilities | ¥554.93B |
| Shareholders' equity | ¥232.74B |
| Equity / assets | 29.5% |
| Operating cash flow | ¥11.05B |
| Capital expenditure | ¥14.15B |
| Free cash flow | ¥-3.10B |
| Cash conversion (OCF / net income) | 270% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中国银行 ・ 中金公司 ・ 中信银行 ・ 中科曙光 ・ 药明康德 ・ 合盛硅业 ・ 海天味业 ・ 华勤技术 ・ 今世缘 ・ 万泰生物 ・ 豪威集团 ・ 华友钴业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies